Bimodular CRISPR/Cas-lentiviral Vector for Modeling Diseases
Publication
, Conference
Kantor, B; Chiba-Falek, O
Published in: MOLECULAR THERAPY
2022
Duke Scholars
Published In
MOLECULAR THERAPY
EISSN
1525-0024
ISSN
1525-0016
Publication Date
2022
Volume
30
Issue
4
Start / End Page
93 / 94
Related Subject Headings
- Biotechnology
- 3206 Medical biotechnology
- 3202 Clinical sciences
- 3105 Genetics
- 11 Medical and Health Sciences
- 10 Technology
- 06 Biological Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Kantor, B., & Chiba-Falek, O. (2022). Bimodular CRISPR/Cas-lentiviral Vector for Modeling Diseases. In MOLECULAR THERAPY (Vol. 30, pp. 93–94).
Kantor, Boris, and Ornit Chiba-Falek. “Bimodular CRISPR/Cas-lentiviral Vector for Modeling Diseases.” In MOLECULAR THERAPY, 30:93–94, 2022.
Kantor B, Chiba-Falek O. Bimodular CRISPR/Cas-lentiviral Vector for Modeling Diseases. In: MOLECULAR THERAPY. 2022. p. 93–4.
Kantor, Boris, and Ornit Chiba-Falek. “Bimodular CRISPR/Cas-lentiviral Vector for Modeling Diseases.” MOLECULAR THERAPY, vol. 30, no. 4, 2022, pp. 93–94.
Kantor B, Chiba-Falek O. Bimodular CRISPR/Cas-lentiviral Vector for Modeling Diseases. MOLECULAR THERAPY. 2022. p. 93–94.
Published In
MOLECULAR THERAPY
EISSN
1525-0024
ISSN
1525-0016
Publication Date
2022
Volume
30
Issue
4
Start / End Page
93 / 94
Related Subject Headings
- Biotechnology
- 3206 Medical biotechnology
- 3202 Clinical sciences
- 3105 Genetics
- 11 Medical and Health Sciences
- 10 Technology
- 06 Biological Sciences